Insights

Innovative Diagnostic Technology PathoGene is developing a cutting-edge sample-to-answer in vitro diagnostic device utilizing advanced robotic automation, third-generation DNA and RNA sequencing, and cloud computing, offering rapid six-hour pathogen detection and antimicrobial resistance profiling which can be highly valuable for hospitals and clinics seeking rapid, accurate diagnostics.

Public Health Impact The company's focus on real-time molecular diagnosis positions it as a key partner for public health agencies and disease surveillance programs looking to improve infectious disease monitoring and response capabilities.

Funding and Growth Potential Having secured $500K in seed funding and generating revenues between $1M and $10M, PathoGene shows promising growth potential in a sector dominated by large players, offering opportunities for strategic partnerships and customer acquisition.

Technological Edge The integration of automation, sequencing, and cloud technology enables PathoGene to offer a potentially scalable and competitive diagnostic solution, appealing to laboratories and healthcare providers aiming for high-throughput infectious disease testing.

Market Positioning As an early-stage innovator in precision MedTech with a focus on infectious diseases, PathoGene can leverage its unique technology for differentiating itself from traditional lab services, providing a compelling value proposition to healthcare systems seeking rapid, comprehensive pathogen detection.

PathoGene, Inc. Tech Stack

PathoGene, Inc. uses 8 technology products and services including AT Internet XiTi, jQuery CDN, Open Graph, and more. Explore PathoGene, Inc.'s tech stack below.

  • AT Internet XiTi
    Analytics
  • jQuery CDN
    Content Delivery Network
  • Open Graph
    Content Management System
  • Google Workspace
    Email
  • Google Fonts API
    Font Scripts
  • Impact Radius
    Hosting Panels
  • jQuery
    Javascript Libraries
  • Cloudflare Bot Management
    Security

PathoGene, Inc.'s Email Address Formats

PathoGene, Inc. uses at least 1 format(s):
PathoGene, Inc. Email FormatsExamplePercentage
FirstLast@pathogene.comJohnDoe@pathogene.com
75%
FLast@pathogene.comJDoe@pathogene.com
25%

Frequently Asked Questions

Where is PathoGene, Inc.'s headquarters located?

Minus sign iconPlus sign icon
PathoGene, Inc.'s main headquarters is located at 605 East Huntington Drive Suite #103 Monrovia, California 91016 United States. The company has employees across 2 continents, including North AmericaOceania.

What is PathoGene, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
PathoGene, Inc.'s official website is pathogene.com and has social profiles on LinkedInCrunchbase.

What is PathoGene, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
PathoGene, Inc.'s SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does PathoGene, Inc. have currently?

Minus sign iconPlus sign icon
As of April 2026, PathoGene, Inc. has approximately 2 employees across 2 continents, including North AmericaOceania. Key team members include Chief Executive Officer: J. M.Chief Data Officer: C. P.Cofounder & Chief Visionary Officer: J. M.. Explore PathoGene, Inc.'s employee directory with LeadIQ.

What industry does PathoGene, Inc. belong to?

Minus sign iconPlus sign icon
PathoGene, Inc. operates in the Medical Equipment Manufacturing industry.

What technology does PathoGene, Inc. use?

Minus sign iconPlus sign icon
PathoGene, Inc.'s tech stack includes AT Internet XiTijQuery CDNOpen GraphGoogle WorkspaceGoogle Fonts APIImpact RadiusjQueryCloudflare Bot Management.

What is PathoGene, Inc.'s email format?

Minus sign iconPlus sign icon
PathoGene, Inc.'s email format typically follows the pattern of FirstLast@pathogene.com. Find more PathoGene, Inc. email formats with LeadIQ.

How much funding has PathoGene, Inc. raised to date?

Minus sign iconPlus sign icon
As of April 2026, PathoGene, Inc. has raised $500K in funding. The last funding round occurred on Jul 14, 2021 for $500K.

When was PathoGene, Inc. founded?

Minus sign iconPlus sign icon
PathoGene, Inc. was founded in 2020.
PathoGene, Inc. logo

PathoGene, Inc.

Medical Equipment ManufacturingCalifornia, United States2-10 Employees

PathoGene, Inc. is a seed-stage medical device company focused on developing a sample-to-answer in vitro diagnostic platform intended to detect and identify all known microscopic human pathogens and their antimicrobial resistance profiles within a single six-hour test. Headquartered in Los Angeles with R&D operations in Monrovia, California, the privately held startup aims to provide rapid molecular diagnostics that can inform treatment decisions and support disease surveillance in real time. The company serves the medical field, targeting doctors, medical staff, and care facilities that require timely, accurate pathogen identification and resistance information to optimize patient care. Positioned within the medical equipment manufacturing industry, PathoGene emphasizes an integrated, automated workflow to deliver diagnostic results that could become a standard of care for infectious disease diagnosis, operating from its California base at the intersection of robotics, sequencing, and data integration. A recent development noted is the company’s ongoing work on its sample-to-answer technology, reflecting its focus on advancing diagnostic capabilities in the infectious disease space.

Section iconCompany Overview

Headquarters
605 East Huntington Drive Suite #103 Monrovia, California 91016 United States
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2020
Employees
2-10

Section iconFunding & Financials

  • $500K

    PathoGene, Inc. has raised a total of $500K of funding over 1 rounds. Their latest funding round was raised on Jul 14, 2021 in the amount of $500K.

  • $1M$10M

    PathoGene, Inc.'s revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $500K

    PathoGene, Inc. has raised a total of $500K of funding over 1 rounds. Their latest funding round was raised on Jul 14, 2021 in the amount of $500K.

  • $1M$10M

    PathoGene, Inc.'s revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.